Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders

Y Masaki, Lei Dong, Nobuyuki Kurose, +29

Annals of the Rheumatic Diseases

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis

Takako Saeki, Shinichi Nishi, Naofumi Imai, +21

Kidney International

Glomerular DiseaseGlomerulonephritisAutoimmune DiseaseVasculitisLupus Nephritis +6

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

Motoko Yamaguchi, Ritsuro Suzuki, Masahiko Oguchi, +23

Journal of Clinical Oncology

Localized EnklLymphoid NeoplasiaMedicineImmunodeficienciesImmunology +13

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab

Kana Miyazaki, Motoko Yamaguchi, Ritsuro Suzuki, +17

Annals of Oncology

Retrospective StudyLymphoid NeoplasiaHematological MalignancyMedicineHematology +6

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial

Kazuyuki Shimada, Motoko Yamaguchi, Yoshiko Atsuta, +31

The Lancet Oncology

Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology +8

Gene expression profiling of peripheral T-cell lymphoma including γδ T-cell lymphoma

Kana Miyazaki, Motoko Yamaguchi, Hiroshi Imai, +6

Blood

DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study

Kana Miyazaki, Naoko Asano, Tomomi Yamada, +21

Haematologica

ImmunologyPathologyPhase Ii StudyPharmacotherapyMetronomic Chemotherapy +17

A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial

Ken Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, +30

Blood Advances

Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma

Hyera Kim, Hyehyun Jeong, Motoko Yamaguchi, +16

Blood

<i>MYD88</i>, <i>CD79B</i>, and <i>CARD11</i> gene mutations in CD5‐positive diffuse large B‐cell lymphoma

Toshifumi Takeuchi, Motoko Yamaguchi, Kyoko Kobayashi, +7

Cancer